Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Ehlers-Danlos Syndrome clinical trials
3 of 6 indexed Ehlers-Danlos Syndrome trials are currently recruiting.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Ehlers-Danlos Syndrome: 6 US clinical trials tracked, 3 recruiting.
Ehlers-Danlos Syndrome is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is Andres Schanzer, running 1 of these trials.
Enrollment posture brief
Registry condition ehlers-danlos-syndrome
OPEN 3 | RECR 50% | LATE 0 | EARLY 0 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Achalasia (50% recruiting · 8 trials)
Ehlers-Danlos Syndrome lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Ehlers-Danlos Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Ehlers-Danlos Syndrome is recruiting above its size-band peers.
3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Ehlers-Danlos Syndrome research.
Andres Schanzer accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Ehlers-Danlos Syndrome enrolment sits around 600 participants.
Median target enrolment is 600 among the 6 trials that report a genuine target (sentinel values excluded). 1 of those (16.7%) plan for fewer than 100 participants.
-
Ehlers-Danlos Syndrome splits between interventional and observational designs.
3 interventional and 3 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
xCures
NCT06539169
Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices
Andres Schanzer
NCT02050113
Light Exposure on Pain in Hypermobile Ehlers-Danlos Syndrome
New York Institute of Technology
NCT05561270
Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers
Vanderbilt University Medical Center
NCT04036305
Study of Heritable Connective Tissue Disorders
National Human Genome Research Institute (NHGRI)
NCT00001641
Assessment of Small Fiber Neuropathy in Rare Diseases Using Sudoscan
Massachusetts General Hospital
NCT02985710
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Ehlers-Danlos Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Ehlers-Danlos Syndrome trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Ehlers-Danlos Syndrome page
6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Ehlers-Danlos Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Andres Schanzer sponsors the most Ehlers-Danlos Syndrome trials on record, review their full trial history before evaluating a specific study. See Andres Schanzer's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ehlers-Danlos Syndrome condition card totals 6 registered trials; most-linked intervention QSART; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.